Targeting cytohesin-1 suppresses acute myeloid leukemia progression and overcomes resistance to ABT-199.
Ren WX, Guo H, Lin SY, Chen SY, Long YY, Xu LY, Wu D, Cao YL, Qu J, Yang BL, Xu HP, Li H, Yu YL, Zhang AY, Wang S, Zhang YC, Zhou KS, Chen ZC, Li QB.
Ren WX, et al. Among authors: wu d.
Acta Pharmacol Sin. 2024 Jan;45(1):180-192. doi: 10.1038/s41401-023-01142-2. Epub 2023 Aug 29.
Acta Pharmacol Sin. 2024.
PMID: 37644132